{"article_title": "Congressional Briefing Addresses Implementation of Biologics Price Competition and Innovations Act", "article_keywords": ["living", "arthritis", "patient", "addresses", "foundation", "implementation", "price", "global", "biologics", "innovations", "biosimilars", "healthy", "state", "competition", "pediatric", "act", "briefing", "rheumatology", "congressional"], "article_url": "http://www.businesswire.com/news/home/20150710005041/en/Congressional-Briefing-Addresses-Implementation-Biologics-Price-Competition", "article_text": "UPPER NYACK, N.Y.--(BUSINESS WIRE)--The Global Healthy Living Foundation, working with the Coalition of State Rheumatology Organizations (CRSO) and the Arthritis Foundation, in cooperation with the Congressional Arthritis Caucus, will co-host a congressional briefing to address the forthcoming availability of biosimilars in light of the U.S. Food and Drug Administration (FDA) not providing final guidance on the approval of biosimilars and interchangeable biological products when it comes to naming, substitution, interchangeability and labeling.\n\nWHAT: \u201cBiosimilars for Arthritis Patients: Challenges and Opportunities\u201d\n\nWHEN: Monday, July 13 from 12-1:00pm EDT\n\nWHERE: B340 Rayburn\n\nWHO: Panelists will address the implementation of the Biologics Price Competition and Innovation Act (BPCIA), which was passed in 2010 as part of the Affordable Care Act. Scheduled to speak and available for interview in advance of the briefing are:\n\nDr. Harry Gewanter, Pediatric Rheumatologist, Pediatric & Adolescent HealthPartners; Clinical Associate Professor of Pediatrics, Virginia Commonwealth University School of Medicine\n\nKim Greco, Director, Global Regulatory and R&D Policy, Amgen\n\nKatherine Macfarlane, Patient Advocate, Global Healthy Living Foundation\n\nJim McKay, PhD, Director, Clinical Development and Medical Affairs Sandoz Biopharmaceuticals (a Novartis Company)\n\nDr. Gregory Schimizzi, Cofounder, Carolina Arthritis; Treasurer, Coalition of State Rheumatology Organizations\n\nAbout the Global Healthy Living Foundation:\n\nThe Global Healthy Living Foundation is a 501(c)(3) non-profit organization whose mission is to improve the quality of life for people living with chronic illnesses by advocating for improved access to care at the community, state, and federal levels, and amplifying education and awareness efforts within its social media framework. The Global Healthy Living Foundation is the parent organization of CreakyJoints, the online, non-profit, arthritis patient support community with more than 80,000 members and their families in all 50 states, Western Europe, South America and Australia, and the recently launched Arthritis Power, the first ever patient-led, patient-generated, patient-centered research registry for arthritis.", "article_metadata": {"description": "The Global Healthy Living Foundation with partners and in cooperation with the Congressional Arthritis Caucus, will co-host a congressional briefing o", "og": {"image": {"width": 465, "identifier": "http://www.businesswire.com/images/bwlogo_square.png", "type": "image/png", "height": 225}}, "twitter": {"description": "The Global Healthy Living Foundation with partners and in cooperation with the Congressional Arthritis Caucus, will co-host a congressional briefing o", "title": "Congressional Briefing Addresses Implementation of Biologics Price Competition and Innovations Act", "image": {"src": "http://mms.businesswire.com/media/20150710005041/en/476253/21/GHLF_Logo.jpg"}, "site": "@businesswire", "widgets": {"csp": "on"}, "card": "summary_large_image"}, "robots": "noodp,noydir", "DC.date.issued": "2015-07-10", "p": {"domain_verify": "95725e0359a14c2e1ccbd936e10d20d6"}, "viewport": "width=device-width,initial-scale=1"}, "_id": "\"57477af46914bd0286fd7c59\"", "article_summary": "WHAT: \u201cBiosimilars for Arthritis Patients: Challenges and Opportunities\u201dWHEN: Monday, July 13 from 12-1:00pm EDTWHERE: B340 RayburnWHO: Panelists will address the implementation of the Biologics Price Competition and Innovation Act (BPCIA), which was passed in 2010 as part of the Affordable Care Act.\nThe Global Healthy Living Foundation is the parent organization of CreakyJoints, the online, non-profit, arthritis patient support community with more than 80,000 members and their families in all 50 states, Western Europe, South America and Australia, and the recently launched Arthritis Power, the first ever patient-led, patient-generated, patient-centered research registry for arthritis.\nUPPER NYACK, N.Y.--(BUSINESS WIRE)--The Global Healthy Living Foundation, working with the Coalition of State Rheumatology Organizations (CRSO) and the Arthritis Foundation, in cooperation with the Congressional Arthritis Caucus, will co-host a congressional briefing to address the forthcoming availability of biosimilars in light of the U.S. Food and Drug Administration (FDA) not providing final guidance on the approval of biosimilars and interchangeable biological products when it comes to naming, substitution, interchangeability and labeling.\nScheduled to speak and available for interview in advance of the briefing are:Dr. Harry Gewanter, Pediatric Rheumatologist, Pediatric & Adolescent HealthPartners; Clinical Associate Professor of Pediatrics, Virginia Commonwealth University School of MedicineKim Greco, Director, Global Regulatory and R&D Policy, AmgenKatherine Macfarlane, Patient Advocate, Global Healthy Living FoundationJim McKay, PhD, Director, Clinical Development and Medical Affairs Sandoz Biopharmaceuticals (a Novartis Company)Dr. Gregory Schimizzi, Cofounder, Carolina Arthritis; Treasurer, Coalition of State Rheumatology OrganizationsAbout the Global Healthy Living Foundation:The Global Healthy Living Foundation is a 501(c)(3) non-profit organization whose mission is to improve the quality of life for people living with chronic illnesses by advocating for improved access to care at the community, state, and federal levels, and amplifying education and awareness efforts within its social media framework."}